• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Stock Down 15% Today





















Did you listen to the earnings call? This is what you get when two fucking accountants are in charge. All they could talk about was expense control. This is what two plus years in a row. Stanley talks about programs to grow sales, he isn't a CPA. Patterson is fucked.